Trial reportBMC psychiatry2025
Effects of community-based rehabilitation on caregivers of people with schizophrenia in Ethiopia in the RISE trial.
Trial report in BMC psychiatry, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT02160249 (RISE), which is not on this map. Cited by 2 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
RISE (Rehabilitation Intervention for People With Schizophrenia in Ethiopia): a Cluster-randomised Trial
Who cites it
2 citing papers in PubMed.
- Real-world comprehensive care of people living with schizophrenia: recommendations across different settings and clinical stages.World psychiatry : official journal of the World Psychiatric Association (WPA) · 2026Article
- Barriers and facilitators to sexual and reproductive healthcare access for women with severe mental illness in low- and middle-income countries: A qualitative systematic review and meta-aggregation.Global mental health (Cambridge, England) · 2026Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors.
Funding
Abstract
backgroundSchizophrenia is a severe mental health condition with high impact on those affected and their families. Community-based rehabilitation (CBR) is a recommended treatment component for schizophrenia in low- and middle-income countries (LMIC), as it seeks to address complex social, health and economic needs. There is little evidence on the effects of CBR on caregivers of people with schizophrenia. RISE, conducted in Ethiopia, was the first randomised controlled trial of CBR for schizophrenia in a low-income country. In this paper, we extend our previous examination of caregiver impact by (1) investigating the impact of CBR on caregiver stigma and burden, (2) assessing effect modification of outcomes, and (3) determining predictors of caregiver outcomes at 12 months.
methodsData are from the cluster-randomised controlled RISE trial, which investigated CBR and facility-based care versus facility-based care alone among 166 people with schizophrenia and 166 linked caregivers in 48 sub-districts in Ethiopia. We analyse the effect of CBR on caregiver stigma, unemployment and burden measured with the WHO Family Interview Schedule-Impact at 6 and 12 months; and caregiver depression, reduction in work due to caregiving and caregiver burden measured with the Involvement Evaluation Questionnaire at 6 months. Logistic and linear regression models adjusted for clustering by sub-district and health centre were used for binary and continuous outcomes respectively. Effect modification by caregiver sex, age, baseline of the outcome, and baseline disability were assessed. Baseline factors associated with caregiver outcomes across the whole cohort at 12 months were investigated using hierarchal regression modelling.
resultsData were available for 112 caregivers at 6 months (67%), and 149 caregivers at 12 months (90%). There was evidence that CBR was associated with greater tendency to reduce work due to caregiving at 6 months (OR:2.40, 95%CI:1.06-5.45). No evidence of an intervention effect was found on unemployment, depression, stigma or other aspects of caregiver burden. There was no evidence for effect modification. Higher baseline disability was independently associated with greater caregiving burden at 12 months (β:0.26, 95%CI:0.14-0.37).
conclusionsThere appeared to be no positive intervention effect of CBR on caregiver stigma, unemployment and burden in this analysis. Improving the outcomes of caregivers of people with schizophrenia in LMIC requires interventions and research addressing the needs of caregivers, for instance by integrating social and livelihoods interventions.
trial registrationClinical Trials.gov Identifier NCT02160249. Registered on 3 June 2014.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.